[BOOK][B] The Indian constitution--: a case study of backward classes

RG Revankar - 1971 - books.google.com
Deals with the problems of the Backward Classes in the vast subcontinent of India. Specific
discussions concentrate on social-reform particulars such as housing, social services …

A randomized trial of ethyl lauroyl arginate‐containing mouthrinse in the control of gingivitis

…, C Mordas, R Gambogi, R Revankar… - Journal of clinical …, 2015 - Wiley Online Library
Aim This 4‐week, single‐centre, randomized, examiner‐blind, controlled study investigated
the efficacy and safety of 0.15% ethyl lauroyl arginate ( LAE )‐containing mouthrinse in …

BMS-986278, a lysophosphatidic acid 1 (LPA1) receptor antagonist, in healthy participants: a single/multiple ascending dose (SAD/MAD) phase 1 study

G Tirucherai, D Yu, R Revankar, G Klinger, JJ Van Lier… - 2019 - Eur Respiratory Soc
Introduction: The LPA 1 receptor is implicated in IPF pathogenesis. BMS-986278 is a potent
small molecule LPA 1 receptor antagonist being investigated for IPF. This study evaluated …

Early benefits with daily rinsing on gingival health improvements with an essential oil mouthrinse–post–hoc analysis of 5 clinical trials

CA Charles, TA Lisante, R Revankar… - American Dental …, 2014 - jdh.adha.org
Purpose: The aim of this investigation through post-hoc analyses was to determine the ability
to achieve gingival health in the short term with daily rinsing with an essential oil containing …

[PDF][PDF] Pharmacokinetics and safety of pegbelfermin (BMS-986036) administered in the abdomen and upper arm to normal, overweight, and obese healthy participants

GS Tirucherai, J Mora, R Revankar, ED Charles - J Hepatol, 2019 - postersessiononline.eu
… Tirucherai, Johanna Mora, Ratna Revankar, Edgar D. Charles … ∎ GS Tirucherai, J Mora,
R Revankar, and ED Charles are employees of Bristol-Myers Squibb and may own …

Gingival health benefits of essential oil, 0.075% cetylpyridinium chloride and control mouthrinses: A 4-week randomized clinical study.

…, JR Cortelli, D Aquino, R Revankar… - American journal of …, 2015 - europepmc.org
Purpose This randomized, single center, examiner-blind, controlled, parallel-group, 4-week
clinical study compared the antiplaque/anti-gingivitis efficacy of an essential oil (EO) …

Use of the Modified Functional Status Questionnaire to Assess Functioning in Patients with Parkinson's Disease Psychosis Treated with Pimavanserin (P5-9.005)

N Rashid, L Chrones, R Revankar, D Doshi, V Abler… - Neurology, 2024 - AAN Enterprises
Objective: In this analysis, we provide additional data on the patient-reported mFSQ within
specific domains. Background: Individuals with Parkinson’s disease psychosis (PDP) face …

Effect of rifampin, a potent organic-anion-transporting polypeptide inhibitor (OATPi), on the PK of BMS-986278, a lysophosphatidic acid receptor (LPA1) antagonist

G Tirucherai, Q Ruan, D Hawthorne, D Yu, R Revankar… - 2020 - Eur Respiratory Soc
Introduction: BMS-986278 is being investigated as a treatment (tx) for idiopathic pulmonary
fibrosis (IPF). In vitro studies demonstrated that OATP mediates human hepatic uptake of …

[CITATION][C] The Indian court: A case study of backward classes

RG Revankar - 1971 - Farleigh Dickinson University Press …